Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review
Angela Raffaella Losito, Francesca Raffaelli, Paola Del Giacomo, et al.
Antibiotics (2022) Vol. 11, Iss. 5, pp. 579-579
Open Access | Times Cited: 61

Showing 26-50 of 61 citing articles:

Bioinformatics and Genomic Analyses of the Suitability of Eight Riboswitches for Antibacterial Drug Targets
Nikolet Pavlova, Robert Penchovsky
Antibiotics (2022) Vol. 11, Iss. 9, pp. 1177-1177
Open Access | Times Cited: 14
Antibacterial and Anti-Biofilm Activities of Microbial Synthesized Silver and Magnetic Iron Oxide Nanoparticles Against Pseudomonas aeruginosa
Mahbobeh Baghiat Esfahani, Alireza Khodavandi, Fahimeh Alizadeh, et al.
IEEE Transactions on NanoBioscience (2023) Vol. 22, Iss. 4, pp. 956-966
Closed Access | Times Cited: 7
Prevalence and Clinical Characteristics of Bacterial Pneumonia in Neurosurgical Emergency Center Patients: A Retrospective Study Spanning 13 Years at a Tertiary Center
Weijian Yang, Haijun Yao, Caihua Xi, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 1992-1992
Open Access | Times Cited: 7
Dipicolylamine‐Zn Induced Targeting and Photo‐Eliminating of Pseudomonas aeruginosa and Drug‐Resistance Gram‐Positive Bacteria
Zuokai Wang, Wenlin Cai, Fangrui Ning, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 6
Closed Access | Times Cited: 7
Molecular epidemiology and carbapenem resistance mechanisms of Pseudomonas aeruginosa isolated from a hospital in Fujian, China
Xueqin Xie, Zhou Liu, Jingyan Huang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
The Challenge of Treating Infections Caused by Metallo‐β‐Lactamase–Producing Gram-Negative Bacteria: A Narrative Review
Carmen Hidalgo‐Tenorio, Germán Bou, Antonio Oliver, et al.
Drugs (2024)
Open Access | Times Cited: 2
Antibiotic resistance in Pseudomonas aeruginosa : mechanisms and emerging treatment
Jian Yang, Jin‐Fu Xu, Shuo Liang
Critical Reviews in Microbiology (2024), pp. 1-19
Closed Access | Times Cited: 2
Novel agents in development for multidrug-resistant Gram-negative infections: potential new options facing multiple challenges
Radhika Arya, Breanna S. Goldner, Andrew F. Shorr
Current Opinion in Infectious Diseases (2022) Vol. 35, Iss. 6, pp. 589-594
Closed Access | Times Cited: 10
The Role of the Respiratory Microbiome in the Pathogenesis of Aspiration Pneumonia: Implications for Diagnosis and Potential Therapeutic Choices
Natalia G. Vallianou, Alexandros Skourtis, Dimitris Kounatidis, et al.
Antibiotics (2023) Vol. 12, Iss. 1, pp. 140-140
Open Access | Times Cited: 6
The primary pharmacology of ceftazidime/avibactam: microbiology from clinical studies, and development of resistance during treatment
Wright W. Nichols, Patricia A. Bradford, Gregory G. Stone
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 4, pp. 871-892
Closed Access | Times Cited: 6
Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC β-Lactamases in Pseudomonas aeruginosa
Isabel M. Barceló, Elena Jordana‐Lluch, María Escobar‐Salom, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 9
The Challenge of Bacteremia Treatment due to Non-Fermenting Gram-Negative Bacteria
Svetlana Sadyrbaeva-Dolgova, María Del Mar Sánchez Suárez, Juan Antonio Reguera, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 899-899
Open Access | Times Cited: 5
Rapid development of cefiderocol resistance in a carbapenem-resistant Pseudomonas aeruginosa isolate associated with mutations in the pyoverdine biosynthesis pathway
Luise Brakert, Laura Berneking, Anna Both, et al.
Journal of Global Antimicrobial Resistance (2023) Vol. 34, pp. 59-62
Open Access | Times Cited: 4
Beyond Antibiotics: Emerging Antivirulence Strategies to Combat Pseudomonas Aeruginosa in Cystic Fibrosis
Umang Mudgil, Lavanya Khullar, Jatin Chadha, et al.
(2024)
Open Access | Times Cited: 1
Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications
Isabel M. Barceló, María Escobar‐Salom, Gabriel Cabot, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 5
Open Access | Times Cited: 1
Bacterial Quality and Molecular Detection of Food Poisoning Virulence Genes Isolated from Nasser Lake Fish, Aswan, Egypt
Nady Khairy Elbarbary, Mohamed K. Dandrawy, Ghada Hadad, et al.
International Journal of Food Science (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Genomic Insights into Vietnamese Extended-Spectrum β-Lactamase-9-Producing Extensively Drug-Resistant Pseudomonas aeruginosa Isolates Belonging to High-Risk Clone ST357 Obtained from Bulgarian Intensive Care Unit Patients
Tanya Strateva, Alexander Stratev, Slavil Peykov
Pathogens (2024) Vol. 13, Iss. 9, pp. 719-719
Open Access | Times Cited: 1
Redefining Infection Management in Implant-based Breast Reconstruction: Insights and Innovations from an 11-Year Retrospective Analysis
Glenda Giorgia Caputo, Anna Scarabosio, Jacopo Di Filippo, et al.
Journal of Plastic Reconstructive & Aesthetic Surgery (2024) Vol. 100, pp. 82-92
Closed Access | Times Cited: 1
Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of Pseudomonas aeruginosa and Enterobacterales from Five Latin American Countries
Juan Carlos García-Betancur, Elsa De La Cadena, María F. Mojica, et al.
Antibiotics (2022) Vol. 11, Iss. 8, pp. 1101-1101
Open Access | Times Cited: 6
New alternative therapeutic strategies against Pseudomonas aeruginosa, an opportunistic multi-resistant pathogen with a myriad of virulence factors
Ihssane Benzaarate, Elotmani Fatima, Khazaz Aboubakr, et al.
The Journal of Infection in Developing Countries (2023) Vol. 17, Iss. 07, pp. 891-904
Open Access | Times Cited: 3
Evolving trends among Pseudomonas aeruginosa: a 12-year retrospective study from the United Arab Emirates
Jens Thomsen, Godfred Antony Menezes, Najiba M. Abdulrazzaq, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 3
“Antibiotic hypersensitivity reactions in Cystic Fibrosis: A thorough inspection on a stumbling block in patient care”
Effie Skevofilax, Maria Moustaki, Ioanna Loukou, et al.
Paediatric Respiratory Reviews (2024) Vol. 51, pp. 56-65
Closed Access
Isolation of Pseudomonas Aeruginosa and Studying their Resistance and Pyocyanin Production.
Farah Hameed
Deleted Journal (2024), pp. 24-31
Open Access
Effect of Incubation Time on Zone Size of Antimicrobials by Disk Diffusion Method for Pseudomonas Aeruginosa
Mehwish Saba Aslam, Muhammad Abid Farooque, Faiqa Imran, et al.
Journal of Health and Rehabilitation Research (2024) Vol. 4, Iss. 2, pp. 854-858
Open Access
Microbiological Diagnosis in the Era of Antimicrobial Resistance
Gian María Rossolini, Alberto Antonelli, Angelo Galano, et al.
Updates in surgery/Updates in surgery series (2024), pp. 71-80
Open Access

Scroll to top